![Maurus de la Rosa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maurus de la Rosa
Chief Tech/Sci/R&D Officer at
ABIVAX
Profile
Maurus de la Rosa is Senior Vice President-Research at Abivax SA since 2026.
Formerly, Dr. de la Rosa was Vice President-Research at Sangamo Therapeutics,.
Inc. Education includes an undergraduate degree from Universität zu Köln and a doctorate from Humboldt-Universität zu Berlin.
Maurus de la Rosa active positions
| Companies | Position | Start |
|---|---|---|
| ABIVAX | Chief Tech/Sci/R&D Officer | 19/03/2026 |
Former positions of Maurus de la Rosa
| Companies | Position | End |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Maurus de la Rosa
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Humboldt-Universität zu Berlin
 Humboldt-Universität zu Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
- Stock Market
- Insiders
- Maurus de la Rosa
